Cyst Fluid Carcinoembryonic Antigen Level Difference between Mucinous Cystic Neoplasms and Intraductal Papillary Mucinous Neoplasms

키워드

참고문헌 (32)

1. Zerboni G, "Systematic review and meta-analysis : prevalence of incidentally detected pancreatic cystic lesions in asymptomatic individuals", Pancreatology, 19, pp.2~9 (2019)
2. Basturk O, "Pancreatic cysts : pathologic classification, differential diagnosis, and clinical implications", Arch Pathol Lab Med, 133, pp.423~438 (2009)
3. van Huijgevoort NCM, "Diagnosis and management of pancreatic cystic neoplasms : current evidence and guidelines", Nat Rev Gastroenterol Hepatol, 16, pp.676~689 (2019)
4. Sentürk H, "Management of cystic diseases of the pancreas", Turk J Gastroenterol, 25, pp.1~18 (2014)
5. Basturk O, "A revised classification system and recommendations from the Baltimore consensus meeting for neoplastic precursor lesions in the pancreas", Am J Surg Pathol, 39, pp.1730~1741 (2015)
6. Adsay NV, "WHO classification of tumours of the digestive system", pp.304~313 (2010), International Agency for Research on Cancer
7. Tanaka M, "International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas", Pancreatology, 6, pp.17~32 (2006)
8. Tanaka M, "International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas", Pancreatology, 12, pp.183~197 (2012)
9. Senturk H, "Needle based confocal laser endomicroscopy examination of pancreatic cysts : single center real life results", Gastroenterology, 154(6 Suppl 1), pp.528~ (2018)
10. Basar O, "Feasibility and safety of microforceps biopsy in the diagnosis of pancreatic cysts", Gastrointest Endosc, 88, pp.79~86 (2018)
11. Mittal C, "Technical feasibility, diagnostic yield, and safety of microforceps biopsies during EUS evaluation of pancreatic cystic lesions(with video)", Gastrointest Endosc, 87, pp.1263~1269 (2018)
12. 오세훈, "The Combination of Cyst Fluid Carcinoembryonic Antigen, Cytology and Viscosity Increases the Diagnostic Accuracy of Mucinous Pancreatic Cysts", Gut and Liver, 11(2), pp.283~289 (2017), 거트앤리버 소화기연관학회협의회
13. Tanaka M, "Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas", Pancreatology, 17, pp.738~753 (2017)
14. European Study Group on Cystic Tumours of the Pancreas, "European evidence-based guidelines on pancreatic cystic neoplasms", Gut, 67, pp.789~804 (2018)
15. Elta GH, "ACG clinical guideline : diagnosis and management of pancreatic cysts", Am J Gastroenterol, 113, pp.464~479 (2018)
16. Brugge WR, "Diagnosis of pancreatic cystic neoplasms : a report of the cooperative pancreatic cyst study", Gastroenterology, 126, pp.1330~1336 (2004)
17. van der Waaij LA, "Cyst fluid analysis in the differential diagnosis of pancreatic cystic lesions : a pooled analysis", Gastrointest Endosc, 62, pp.383~389 (2005)
18. Nagula S, "Evaluation of cyst fluid CEA analysis in the diagnosis of mucinous cysts of the pancreas", J Gastrointest Surg, 14, pp.1997~2003 (2010)
19. Park WG, "Diagnostic performance of cyst fluid carcinoembryonic antigen and amylase in histologically confirmed pancreatic cysts", Pancreas, 40, pp.42~45 (2011)
20. Cizginer S, "Cyst fluid carcinoembryonic antigen is an accurate diagnostic marker of pancreatic mucinous cysts", Pancreas, 40, pp.1024~1028 (2011)
21. Al-Rashdan A, "Fluid analysis prior to surgical resection of suspected mucinous pancreatic cysts. A single centre experience", J Gastrointest Oncol, 2, pp.208~214 (2011)
22. Ngamruengphong S, "Cyst carcinoembryonic antigen in differentiating pancreatic cysts : a meta-analysis", Dig Liver Dis, 45, pp.920~926 (2013)
23. Nagashio Y, "Combination of cyst fluid CEA and CA 125 is an accurate diagnostic tool for differentiating mucinous cystic neoplasms from intraductal papillary mucinous neoplasms", Pancreatology, 14, pp.503~509 (2014)
24. Gaddam S, "Suboptimal accuracy of carcinoembryonic antigen in differentiation of mucinous and nonmucinous pancreatic cysts : results of a large multicenter study", Gastrointest Endosc, 82, pp.1060~1069 (2015)
25. Kawai M, "Clinicopathological features of malignant intraductal papillary mucinous tumors of the pancreas : the differential diagnosis from benign entities", Arch Surg, 139, pp.188~192 (2004)
26. Maire F, "Intraductal papillary mucinous neoplasms of the pancreas : performance of pancreatic fluid analysis for positive diagnosis and the prediction of malignancy", Am J Gastroenterol, 103, pp.2871~2877 (2008)
27. Oppong KW, "EUS and EUS-FNA diagnosis of suspected pancreatic cystic neoplasms : is the sum of the parts greater than the CEA?", Pancreatology, 15, pp.531~537 (2015)
28. Correa-Gallego C, "Fluid CEA in IPMNs : a useful test or the flip of a coin?", Am J Gastroenterol, 104, pp.796~797 (2009)
29. Kucera S, "Cyst fluid carcinoembryonic antigen level is not predictive of invasive cancer in patients with intraductal papillary mucinous neoplasm of the pancreas", JOP, 13, pp.409~413 (2012)
30. Scourtas A, "Preoperative characteristics and cytological features of 136histologically confirmed pancreatic mucinous cystic neoplasms", Cancer Cytopathol, 125, pp.169~177 (2017)
31. Hayakawa H, "Carcinoembryonic antigen level in the pancreatic juice is effective in malignancy diagnosis and prediction of future malignant transformation of intraductal papillary mucinous neoplasm of the pancreas", J Gastroenterol, 54, pp.1029~1037 (2019)
32. Hirono S, "Factors associated with invasive intraductal papillary mucinous carcinoma of the pancreas", JAMA Surg, 152, pp.e165054~ (2017)

관련 논문AI추천